RIGI and COVID-19: Pathogen recognition receptor (PRR) RIG-I/MDA5 and GPCR pathways displayed differential behaviour in CD8+ T cells (Fig. 5d) and CD14+ monocytes (Fig. 5e) in severe COVID-19 (D1) and during remission (D5 and D7).